Gregory N. Fuller
Gregory N. Fuller
Professor of Pathology, M D Anderson Cancer Center
Подтвержден адрес электронной почты в домене
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
Cell 155 (2), 462-477, 2013
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma
M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ...
Cell 164 (3), 550-563, 2016
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
EC Holland, J Celestino, C Dai, L Schaefer, RE Sawaya, GN Fuller
Nature genetics 25 (1), 55-57, 2000
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
C Dai, JC Celestino, Y Okada, DN Louis, GN Fuller, EC Holland
Genes & development 15 (15), 1913-1925, 2001
Malignant gliomas: MR imaging spectrum of radiation therapy-and chemotherapy-induced necrosis of the brain after treatment
AJ Kumar, NE Leeds, GN Fuller, P Van Tassel, MH Maor, RE Sawaya, ...
Radiology 217 (2), 377-384, 2000
I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ...
Brain pathology 24 (5), 429-435, 2014
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
JF De Groot, G Fuller, AJ Kumar, Y Piao, K Eterovic, Y Ji, CA Conrad
Neuro-oncology 12 (3), 233-242, 2010
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results
FF Lang, JM Bruner, GN Fuller, K Aldape, MD Prados, S Chang, ...
Journal of Clinical Oncology 21 (13), 2508-2518, 2003
Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.
PA Humphrey, AJ Wong, B Vogelstein, MR Zalutsky, GN Fuller, GE Archer, ...
Proceedings of the National Academy of Sciences 87 (11), 4207-4211, 1990
Limitations of stereotactic biopsy in the initial management of gliomas
RJ Jackson, GN Fuller, D Abi-Said, FF Lang, ZL Gokaslan, WM Shi, ...
Neuro-oncology 3 (3), 193-200, 2001
Sacral chordoma: 40-year experience at a major cancer center
JE York, A Kaczaraj, D Abi-Said, GN Fuller, JM Skibber, NA Janjan, ...
Neurosurgery 44 (1), 74-79, 1999
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
LL Chen, JC Trent, EF Wu, GN Fuller, L Ramdas, W Zhang, AK Raymond, ...
Cancer research 64 (17), 5913-5919, 2004
PD-L1 expression and prognostic impact in glioblastoma
EK Nduom, J Wei, NK Yaghi, N Huang, LY Kong, K Gabrusiewicz, X Ling, ...
Neuro-oncology 18 (2), 195-205, 2015
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro
M Yamamoto, S Mohanam, R Sawaya, GN Fuller, M Seiki, H Sato, ...
Cancer Research 56 (2), 384-392, 1996
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt
L Uhrbom, C Dai, JC Celestino, MK Rosenblum, GN Fuller, EC Holland
Cancer research 62 (19), 5551-5558, 2002
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo, R Alemany, C Gomez-Manzano, GN Fuller, A Khan, CA Conrad, ...
Journal of the National Cancer Institute 95 (9), 652-660, 2003
Sulfonylurea receptor mRNA expression in pituitary macroadenomas
Z Zhu, IE McCutcheon, MBS Lopes, ER Laws, VL Wagner, JM Bruner, ...
Endocrine 8 (1), 7-12, 1998
RET oncogene activation in papillary thyroid carcinoma
G Tallini, SL Asa, GN Fuller
Advances in anatomic pathology 8 (6), 345-354, 2001
Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma
FF Lang, C Conrad, C Gomez-Manzano, WKA Yung, R Sawaya, ...
Journal of Clinical Oncology 36 (14), 1419, 2018
Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas
AB Heimberger, M Abou-Ghazal, C Reina-Ortiz, DS Yang, W Sun, W Qiao, ...
Clinical Cancer Research 14 (16), 5166-5172, 2008
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20